Back to GlossaryDocument

Cosmetic Product Safety Report (CPSR)

A two-part safety assessment document required within the PIF under EC 1223/2009 (Annex I). Part A compiles safety data for each ingredient; Part B is a qualified safety assessor's conclusion on whether the product is safe for human health.

The Cosmetic Product Safety Report (CPSR) is mandated by Annex I of the EU Cosmetics Regulation (EC 1223/2009) and is the core document within the Product Information File (PIF). It must be completed before a cosmetic product is placed on the market and serves as the formal safety assessment demonstrating that the product is safe for human health under normal or reasonably foreseeable conditions of use.

Part A — Cosmetic Product Safety Information compiles all the data needed for the safety assessment: the quantitative and qualitative composition of the product, physical and chemical characteristics, microbiological quality, impurities and traces, packaging material information, normal and reasonably foreseeable use, exposure to the product, exposure to individual substances, toxicological profiles of each substance, undesirable effects, and any other relevant product information.

Part B — Cosmetic Product Safety Assessment must be carried out by a qualified safety assessor who holds a university diploma in pharmacy, toxicology, medicine, or a similar discipline. The assessor evaluates the Part A data and provides a reasoned conclusion on whether the product is safe. The assessment must specifically address the overall product safety conclusion, labeled warnings and instructions, reasoning behind the conclusion, and the assessor's name, qualifications, and signature.

The cost of a CPSR varies from approximately 300 to 900 EUR per product depending on formulation complexity, number of ingredients, and whether the safety assessor requires additional testing data.

Related Terms

Document

Product Information File (PIF)

A mandatory dossier required under EC 1223/2009 (Article 11) that the Responsible Person must maintain for each cosmetic product on the EU market. It contains the CPSR, product description, manufacturing method, GMP evidence, and claims substantiation.

Regulation

EU Cosmetics Regulation (EC 1223/2009)

The primary European Union law governing cosmetic products, establishing requirements for safety assessment, CPNP notification, responsible person designation, ingredient restrictions (Annexes II-VI), labeling, and post-market surveillance across all EU/EEA member states.

Process

Margin of Safety (MoS)

A quantitative measure used in cosmetic safety assessment, calculated as NOAEL divided by Systemic Exposure Dose (SED). A Margin of Safety of 100 or greater is generally considered acceptable by the SCCS, indicating the product is safe under normal conditions of use.

Process

No Observed Adverse Effect Level (NOAEL)

The highest dose or concentration of a substance at which no statistically or biologically significant adverse effects are observed in a toxicological study. The NOAEL is the numerator in the Margin of Safety (MoS) calculation used in cosmetic safety assessment.

Process

Responsible Person

An entity established within the EU (or UK for the GB market) who is legally responsible for ensuring a cosmetic product complies with the Cosmetics Regulation. The Responsible Person maintains the PIF, submits CPNP/SCPN notifications, and reports serious undesirable effects.

See how Cosmetica automates compliance

Replace manual regulatory work with AI-powered automation — from ingredient screening to submission filing.